Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa

被引：9

作者：

Molinelli, Elisa ^{[1
]}

Sapigni, Claudia ^{[1
]}

Simonetti, Oriana ^{[1
]}

Radi, Giulia ^{[1
]}

Gambini, Daisy ^{[1
]}

Maurizi, Andrea ^{[1
]}

Rizzetto, Giulio ^{[1
]}

D'Agostino, Giovanni Marco ^{[1
]}

Offidani, Annamaria ^{[1
]}

机构：

[1] Polytech Marche Univ, Dept Clin & Mol Sci, Dermatol Unit, Ancona, Italy

来源：

DERMATOLOGIC THERAPY | 2022年 / 35卷 / 08期

关键词：

D O I：

10.1111/dth.15645

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：3

共 50 条

[31] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Silverberg, J.
Chao, J.
Eckert, L.
Chen, Z.
Ardeleanu, M.
Shumel, B.
Plaum, S.
Graham, N.
Pirozzi, G.
Gadkari, A.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
[32] Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis
Marcant, P.
Balaye, P.
Merhi, R.
Jendoubi, F.
Nosbaum, A.
Raison-Peyron, N.
Du-Thanh, A.
Lasek, A.
Ferrier le Bouedec, M. -C.
Tetart, F.
Valois, A.
Barbarot, S.
Soria, A.
Jachiet, M.
Staumont-Salle, D.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (06) : E394 - E396
[33] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
Kim, Nicole S.
Maliyar, Khalad
Oliveira, Luciana
O'Toole, Ashley
Gooderham, Melinda J.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
[34] Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis
Staumont-Salle, Delphine
Barbarot, Sebastien
Bouaziz, Jean David
Chan, Chan
Clibborn, Claire
Du-Thanh, Aurelie
Feeney, Claire
Lejeune, Alexandre
Misery, Laurent
Nosbaum, Audrey
Seneschal, Julien
Soria, Angele
Zhang, Fan
JEADV CLINICAL PRACTICE, 2023, 2 (03): : 518 - 530
[35] Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
Hamilton, Jennifer D.
Suarez-Farinas, Mayte
Dhingra, Nikhil
Cardinale, Irma
Li, Xuan
Kostic, Ana
Ming, Jeffrey E.
Radin, Allen R.
Krueger, James G.
Graham, Neil
Yancopoulos, George D.
Pirozzi, Gianluca
Guttman-Yassky, Emma
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (06) : 1293 - 1300
[36] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
Silverberg, Jonathan I.
Chao, Jingdong
Eckert, Laurent
Chen, Zhen
Ardeleanu, Marius
Shumel, Brad
Plaum, Stefan
Graham, Neil M. H.
Pirozzi, Gianluca
Gadkari, Abhijit
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
[37] Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
Ferrucci, Silvia
Casazza, Giovanni
Zussino, Martina
Tavecchio, Simona
Marzano, Angelo V.
Tedeschi, Micol
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
[38] Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis
Beck, Lisa A.
Muraro, Antonella
Boguniewicz, Mark
Chen, Zhen
Zahn, Joseph
Marco, Ainara Rodriguez
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (01)
[39] Moderate-to-severe atopic dermatitis in different age groups treated with dupilumab in China
Song, Xiaoting
Liu, Bo
Luan, Tingting
Liao, Shuanglu
Tan, Yen
Peng, Chengyue
Zhao, Zuotao
ALLERGY, 2023, 78 (06) : 1696 - 1699
[40] Clinically meaningful responses in moderate-to-severe atopic dermatitis patients treated with Dupilumab
de Bruin-Weller, M.
Eckert, L.
Simpson, E. L.
Cork, M. J.
Ardeleanu, M.
Chen, Z.
Shumel, B.
Rossi, A. B.
Graham, N. M. H.
Pirozzi, G.
Gadkari, A.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 116 - 116

← 1 2 3 4 5 →